Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 19 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-0.31 Insider Own53.10% Shs Outstand13.32M Perf Week-3.53%
Market Cap109.25M Forward P/E327.53 EPS next Y0.02 Insider Trans0.64% Shs Float9.39M Perf Month1.49%
Income-4.16M PEG- EPS next Q-0.14 Inst Own9.64% Short Float3.76% Perf Quarter52.51%
Sales80.00M P/S1.37 EPS this Y-338.10% Inst Trans6.27% Short Ratio4.06 Perf Half Y9.64%
Book/sh0.65 P/B8.40 EPS next Y101.81% ROA-5.12% Short Interest0.35M Perf Year200.00%
Cash/sh1.20 P/C4.54 EPS next 5Y- ROE-40.69% 52W Range1.60 - 8.11 Perf YTD-5.21%
Dividend Est.- P/FCF92.59 EPS past 5Y- ROI-15.05% 52W High-32.68% Beta0.93
Dividend TTM- Quick Ratio0.94 Sales past 5Y23.37% Gross Margin66.22% 52W Low241.25% ATR (14)0.39
Dividend Ex-Date- Current Ratio1.21 EPS Y/Y TTM91.15% Oper. Margin0.68% RSI (14)53.52 Volatility7.27% 6.99%
Employees58 Debt/Eq1.37 Sales Y/Y TTM27.82% Profit Margin-5.20% Recom1.00 Target Price9.17
Option/ShortNo / Yes LT Debt/Eq1.13 EPS Q/Q7.15% Payout- Rel Volume0.35 Prev Close5.51
Sales Surprise-7.62% EPS Surprise-125.53% Sales Q/Q6.69% EarningsMay 13 AMC Avg Volume87.03K Price5.46
SMA200.58% SMA5016.46% SMA20024.47% Trades Volume30,816 Change-0.91%
Date Action Analyst Rating Change Price Target Change
Jun-28-24Resumed ROTH MKM Buy $11
Dec-07-21Initiated B. Riley Securities Buy $14
Jul-17-24 04:15PM
Jul-11-24 04:05PM
May-15-24 04:15PM
May-14-24 03:07AM
08:55PM Loading…
May-13-24 08:55PM
May-07-24 08:30AM
May-01-24 04:01PM
Apr-29-24 09:00AM
Apr-25-24 08:30AM
Mar-28-24 04:05PM
Mar-25-24 07:01PM
Mar-22-24 06:01AM
Mar-21-24 09:53PM
04:01PM Loading…
Mar-19-24 08:49AM
Mar-18-24 08:30AM
Mar-15-24 08:30AM
Mar-13-24 08:30AM
Mar-11-24 08:30AM
Feb-26-24 11:35AM
Jan-05-24 08:30AM
Jan-02-24 04:05PM
Dec-27-23 08:50AM
Dec-13-23 08:09AM
Dec-07-23 09:16AM
Dec-06-23 08:00AM
Nov-30-23 12:00PM
Nov-29-23 08:50AM
04:10PM Loading…
Nov-14-23 04:10PM
Nov-12-23 09:36AM
Nov-07-23 04:01PM
Nov-01-23 08:00AM
Oct-31-23 08:30AM
Oct-20-23 08:30AM
Sep-09-23 01:04AM
Sep-07-23 11:45AM
Sep-06-23 08:00AM
Aug-14-23 04:01PM
Aug-08-23 06:05PM
Aug-03-23 05:35PM
Aug-02-23 04:01PM
Jul-19-23 08:30AM
Jul-11-23 08:30AM
Jul-04-23 07:34AM
Jul-03-23 08:00AM
Jun-14-23 12:03PM
Jun-13-23 12:11PM
May-22-23 05:15PM
May-19-23 04:01PM
May-15-23 04:01PM
May-11-23 04:01PM
May-04-23 09:00AM
Apr-19-23 02:22PM
Apr-01-23 09:41PM
Mar-30-23 04:10PM
Mar-29-23 05:15PM
Mar-28-23 05:35PM
Mar-22-23 09:00AM
Mar-16-23 08:30AM
Mar-07-23 08:30AM
Jan-20-23 04:01PM
Jan-10-23 08:30AM
Dec-20-22 10:02AM
Dec-05-22 04:05PM
Nov-13-22 07:38AM
Nov-10-22 05:25PM
Nov-03-22 08:52AM
Oct-04-22 08:30AM
Aug-30-22 08:30AM
Aug-12-22 06:14AM
Aug-09-22 05:55PM
Aug-04-22 10:00AM
Aug-03-22 08:00AM
Jul-18-22 07:05AM
May-24-22 08:30AM
May-23-22 08:30AM
May-16-22 01:20PM
May-10-22 04:01PM
May-03-22 04:15PM
Apr-15-22 09:55AM
Apr-04-22 08:30AM
Apr-01-22 08:30AM
Mar-23-22 04:01PM
Mar-18-22 01:15PM
Mar-17-22 08:30AM
Mar-09-22 08:30AM
Feb-11-22 08:00AM
Jan-13-22 08:38AM
Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROSENWALD LINDSAY A MDDirectorMar 25 '24Buy3.0410,00030,400144,245Mar 27 07:00 AM
Smith Justin AdamDirectorMar 22 '24Buy3.4730,000104,100134,717Mar 25 04:02 PM
ROSENWALD LINDSAY A MDDirectorMar 22 '24Buy3.4020,00068,000134,245Mar 25 04:01 PM
Maraoui ClaudePresident & CEOMar 22 '24Buy3.4810,00034,7902,163,430Mar 25 04:03 PM
Benesch JosephInterim CFOFeb 22 '24Sale3.752,4509,18860,710Feb 23 05:54 PM
Paley JeffreyDirectorNov 28 '23Sale5.221,7459,10970,727Nov 29 04:42 PM
Paley JeffreyDirectorNov 08 '23Sale3.76255959114,217Dec 08 05:01 PM
Paley JeffreyDirectorNov 07 '23Sale3.482,2457,813114,472Dec 08 05:01 PM
Smith Justin AdamDirectorOct 13 '23Buy2.9833,00098,340104,717Oct 17 04:01 PM
Paley JeffreyDirectorOct 06 '23Buy2.9815,00044,70072,472Oct 10 04:41 PM
Paley JeffreyDirectorSep 21 '23Buy2.9730,00089,10057,472Sep 25 04:01 PM
ROSENWALD LINDSAY A MDDirectorSep 06 '23Buy2.23100,000223,000114,245Sep 08 01:25 PM
Maraoui ClaudePresident & CEOSep 06 '23Buy2.5226,04465,6312,153,430Sep 08 01:26 PM
Maraoui ClaudePresident & CEOJul 24 '23Sale1.7620,76736,5502,127,386Jul 25 04:05 PM
Benesch JosephSee RemarksJul 24 '23Sale1.764,0727,16763,160Jul 25 04:05 PM